Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1984-3-21
pubmed:abstractText
Plasma sex hormone binding globulin (SHBG) levels were determined in a group of 82 patients suffering from breast carcinoma with a known estrogen receptor status (ER). Overweight (greater than 20% of ideal weight) premenopausal patients had a significantly lower SHBG plasma level than their non-obese counterparts (43 pmol/ml vs 72.7 pmol/ml, P less than 0.001). No difference in plasma levels of SHBG was found between obese and non-obese postmenopausal patients. No correlation was found between SHBG levels and ER status either in non-obese premenopausal patients or in postmenopausal patients in general. Breast carcinoma patients had significantly higher SHBG plasma levels than a group of normal controls (57.9 pmol/ml vs 40.6 pmol/ml, P less than 0.01), but the stage of the disease did not influence the SHBG level within the breast carcinoma patients. Results of this study do not support a correlation between SHBG levels and ER status. SHBG plasma levels are significantly influenced by a patient's weight, particularly in those who are premenopausal.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0277-5379
pubmed:author
pubmed:issnType
Print
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
19-23
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1984
pubmed:articleTitle
Sex hormone binding globulin (SHBG) in breast cancer: a correlation with obesity but not with estrogen receptor status.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't